Leiden University: Research Improves Risk Assessment for Hereditary Breast Cancer
January 28, 2026
January 28, 2026
LEIDEN, The Netherlands, Jan. 28 (TNSjou) -- Leiden University issued the following news:
* * *
Research improves risk assessment for hereditary breast cancer
Researchers at LUMC have made a breakthrough in understanding PALB2 mutations, an important cause of hereditary breast cancer. By identifying which mutations affect the function of PALB2, doctors can now assess much more accurately which mutations are linked to an increased risk of breast cancer.
* * *
Research improves risk assessment for hereditary breast cancer
Researchers at LUMC have made a breakthrough in understanding PALB2 mutations, an important cause of hereditary breast cancer. By identifying which mutations affect the function of PALB2, doctors can now assess much more accurately which mutations are linked to an increased risk of breast cancer.